Page last updated: 2024-08-20

dextrothyroxine and Granulocytic Leukemia, Chronic

dextrothyroxine has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, J; Wan, H; Wang, J; Xu, Y	1

Other Studies

1 other study(ies) available for dextrothyroxine and Granulocytic Leukemia, Chronic

Article	Year
Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress. Biochemical and biophysical research communications, 2018, 02-26, Volume: 497, Issue:1 Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Apoptosis; Dose-Response Relationship, Drug; Humans; Ivermectin; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Mitochondria; Oxidative Stress; Treatment Outcome	2018

Article

Year

Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress.

Biochemical and biophysical research communications, 2018, 02-26, Volume: 497, Issue:1

Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Apoptosis; Dose-Response Relationship, Drug; Humans; Ivermectin; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Mitochondria; Oxidative Stress; Treatment Outcome

2018